ブルガリア - ブルガリア語 - БАБХ (Българска агенция по безопасност на храните)

bayer animal health gmbh - butaphosphan, Витамин В12 - инжекционен разтвор - 100 mg/ml; 0, 05 mg/ml - говеда, котки, кучета

ブルガリア - ブルガリア語 - БАБХ (Българска агенция по безопасност на храните)

bayer animal health gmbh - coumaphos - лента за пчелен кошер - 100 mg/g - пчели

ブルガリア - ブルガリア語 - БАБХ (Българска агенция по безопасност на храните)

bayer animal health gmbh - Флюметрин - лента за пчелен кошер - 275 mg/лента - пчели

ブルガリア - ブルガリア語 - БАБХ (Българска агенция по безопасност на храните)

bayer animal health gmbh - Фоксим - разтвор за поливане - 75 mg/ml - свине

ブルガリア - ブルガリア語 - БАБХ (Българска агенция по безопасност на храните)

bayer animal health gmbh - Имидаклоприд, Перметрин - течност за прилагане върху ограничен участък - 100 mg/ml, 500 mg/ml - кучета

欧州連合 - ブルガリア語 - EMA (European Medicines Agency)

bayer ag - darolutamide - Новообразувания На Простатата, Кастраци-Упорит - Ендокринна терапия - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

欧州連合 - ブルガリア語 - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - Захарен диабет тип 2 - Лекарства, използвани при диабет - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

欧州連合 - ブルガリア語 - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - Дерматит, Атопич - Други дерматологични препарати - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

ブルガリア - ブルガリア語 - Adama

adama - Суспензионен концентат (СК) - 25 г/л дифлуфеникан + 400 г/л хлоротолурон - Хербициди

欧州連合 - ブルガリア語 - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - Всички други терапевтични продукти - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.